Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate-Sufentanil versus Ketamine-Sufentanil-Midazolam during laryngoscopy and tracheal intubation
IRCT20090129001615N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of etomidate, sufentanil, ketamine and midazolam in None (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 4 more. Started Sep 2020; status: completed.
02
Drugs
etomidatesufentanilketaminemidazolam
Beyond the preview
Go deeper on IRCT20090129001615N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090129001615N4.